Hong Du

760 total citations · 1 hit paper
21 papers, 578 citations indexed

About

Hong Du is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hong Du has authored 21 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Hong Du's work include RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Prostate Cancer Treatment and Research (3 papers). Hong Du is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Prostate Cancer Treatment and Research (3 papers). Hong Du collaborates with scholars based in China, United States and Ethiopia. Hong Du's co-authors include Boyi Song, Ershuai Zhang, Yuanjie Shi, Xiangfei Han, Zhiqiang Cao, Chengbiao Yang, Yang Lü, Ke Wang, Jinbing Xie and Hui Zhu and has published in prestigious journals such as PLoS ONE, Nature Nanotechnology and Bioresource Technology.

In The Last Decade

Hong Du

19 papers receiving 576 citations

Hit Papers

Zwitterionic micelles efficiently deliver oral insulin wi... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Du China 11 265 149 87 82 73 21 578
Jibin Guan China 12 230 0.9× 79 0.5× 80 0.9× 156 1.9× 53 0.7× 29 501
Pradip Chaudhari India 15 311 1.2× 87 0.6× 50 0.6× 166 2.0× 81 1.1× 36 717
Lulu Wang China 13 218 0.8× 92 0.6× 111 1.3× 40 0.5× 49 0.7× 26 458
Jilai Tian China 16 245 0.9× 94 0.6× 53 0.6× 155 1.9× 102 1.4× 32 720
Lingran Du China 11 188 0.7× 73 0.5× 63 0.7× 109 1.3× 30 0.4× 22 457
Anowar Hussain India 11 337 1.3× 68 0.5× 239 2.7× 135 1.6× 28 0.4× 18 658
Yucheng Xiang China 14 253 1.0× 68 0.5× 46 0.5× 111 1.4× 84 1.2× 38 537
Chengcheng Song China 18 418 1.6× 40 0.3× 44 0.5× 95 1.2× 50 0.7× 42 778
Sachin Khiste United States 14 391 1.5× 38 0.3× 162 1.9× 68 0.8× 87 1.2× 20 736

Countries citing papers authored by Hong Du

Since Specialization
Citations

This map shows the geographic impact of Hong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Du more than expected).

Fields of papers citing papers by Hong Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Du. The network helps show where Hong Du may publish in the future.

Co-authorship network of co-authors of Hong Du

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Du. A scholar is included among the top collaborators of Hong Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Du. Hong Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Hong, T. Xiang, Ying Xia, et al.. (2025). Super-enhancer-associated LINC00963 promotes metastasis of gastric cancer through epithelial-mesenchymal transition. PLoS ONE. 20(9). e0332396–e0332396.
2.
Du, Hong. (2025). From Environmental Ethics to Sustainability Ethics. Problemy Ekorozwoju. 20(1). 6–14.
3.
Wang, Min, Lixin He, Baolin Zhang, et al.. (2024). Osteoblast‐Derived ECM1 Promotes Anti‐Androgen Resistance in Bone Metastatic Prostate Cancer. Advanced Science. 12(2). e2407662–e2407662. 3 indexed citations
4.
Wang, Min, Yingzhao Wang, Kai‐Yuan Lin, et al.. (2023). BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer. Journal for ImmunoTherapy of Cancer. 11(3). e005532–e005532. 18 indexed citations
5.
Xia, Ying, et al.. (2023). Super-enhancer-associated EEPD1 facilitates EMT-mediated metastasis by regulating the PI3K/AKT/mTOR pathway in gastric cancer. Biochemical and Biophysical Research Communications. 689. 149188–149188. 6 indexed citations
6.
Shu, Gang, Hong Du, Yilei Zheng, et al.. (2023). Effects of Dietary Ferulic Acid on Intestinal Health and Ileal Microbiota of Tianfu Broilers Challenged with Lipopolysaccharide. Molecules. 28(4). 1720–1720. 9 indexed citations
7.
Du, Hong, et al.. (2023). Microplastic size-dependent biochemical and molecular effects in alga Heterosigma akashiwo. Ecotoxicology and Environmental Safety. 268. 115673–115673. 7 indexed citations
8.
Zheng, Yilei, Hong Du, Wei Zhang, et al.. (2023). The Pathophysiological Changes and Clinical Effects of Tetramethylpyrazine in ICR Mice with Fluoride-Induced Hepatopathy. Molecules. 28(12). 4849–4849. 1 indexed citations
9.
Bi, Ran, Edmond Sanganyado, Xiangfeng Zeng, et al.. (2022). Rare earth elements in oysters and mussels collected from the Chinese coast: Bioaccumulation and human health risks. Marine Pollution Bulletin. 184. 114127–114127. 14 indexed citations
10.
Du, Hong, et al.. (2022). The Regulation of let-7c-5p on the Biological Characteristics of Lung Adenocarcinoma Cells by Targeting AURKB. Molecular Biotechnology. 64(5). 526–534. 4 indexed citations
11.
Huangfu, Longtao, Jing Han, Xiaomei Li, et al.. (2021). MicroRNA-135b/CAMK2D Axis Contribute to Malignant Progression of Gastric Cancer through EMT Process Remodeling. International Journal of Biological Sciences. 17(8). 1940–1952. 17 indexed citations
13.
Han, Xiangfei, Yang Lü, Jinbing Xie, et al.. (2020). Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions. Nature Nanotechnology. 15(7). 605–614. 245 indexed citations breakdown →
14.
Lang, Chuandong, Yuhu Dai, Zhengquan Wu, et al.. (2020). SMAD3/SP1 complex‐mediated constitutive active loop between lncRNA PCAT7 and TGF‐β signaling promotes prostate cancer bone metastasis. Molecular Oncology. 14(4). 808–828. 66 indexed citations
15.
Han, Xiangfei, et al.. (2019). Biomaterial–tight junction interaction and potential impacts. Journal of Materials Chemistry B. 7(41). 6310–6320. 33 indexed citations
16.
Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo. Bioorganic & Medicinal Chemistry Letters. 21(6). 1634–1638. 12 indexed citations
17.
Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part I: Compounds containing a lipophilic C32 side chain overcome P-glycoprotein susceptibility. Bioorganic & Medicinal Chemistry Letters. 21(6). 1630–1633. 16 indexed citations
18.
Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part III: Blood–brain barrier permeability and in vivo activity in a brain tumor model. Bioorganic & Medicinal Chemistry Letters. 21(6). 1639–1643. 16 indexed citations
19.
Du, Hong, et al.. (2011). Higher efficiency of CO2 injection into seawater by a venturi than a conventional diffuser system. Bioresource Technology. 107. 131–134. 10 indexed citations
20.
Kuznetsov, Galina, Qunli Xu, Karen TenDyke, et al.. (2009). Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A. Molecular Cancer Therapeutics. 8(5). 1250–1260. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026